Yu Li

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Systematic Review

Top Venues

Journal of clinical medicine

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Aman, Matthias Schulte, Yu Li, Benjamin F Thomas, Simeon C Daeschler, Maximilian Mayrhofer-Schmid, Ulrich Kneser, Leila Harhaus, Arne Hendrik Boecker
Benefit of Adjuvant Mesenchymal Stem Cell Transplantation to Critical-Sized Peripheral Nerve Defect Repair: A Systematic Review and Meta-Analysis of Preclinical Studies. Journal of clinical medicine 12 (4) (2023)
Martin Aman, Matthias Schulte, Yu Li, Benjamin F Thomas, Simeon C Daeschler, Maximilian Mayrhofer-Schmid, Ulrich Kneser, Leila Harhaus, Arne Hendrik Boecker
Benefit of Adjuvant Mesenchymal Stem Cell Transplantation to Critical-Sized Peripheral Nerve Defect Repair: A Systematic Review and Meta-Analysis of Preclinical Studies. Journal of clinical medicine 12 (4) (2023)
Martin Aman, Matthias Schulte, Yu Li, Benjamin F Thomas, Simeon C Daeschler, Maximilian Mayrhofer-Schmid, Ulrich Kneser, Leila Harhaus, Arne Hendrik Boecker
Benefit of Adjuvant Mesenchymal Stem Cell Transplantation to Critical-Sized Peripheral Nerve Defect Repair: A Systematic Review and Meta-Analysis of Preclinical Studies. Journal of clinical medicine 12 (4) (2023)
Martin Aman, Matthias Schulte, Yu Li, Benjamin F Thomas, Simeon C Daeschler, Maximilian Mayrhofer-Schmid, Ulrich Kneser, Leila Harhaus, Arne Hendrik Boecker
Benefit of Adjuvant Mesenchymal Stem Cell Transplantation to Critical-Sized Peripheral Nerve Defect Repair: A Systematic Review and Meta-Analysis of Preclinical Studies. Journal of clinical medicine 12 (4) (2023)
Yu Li, Ximei Wang
Chrysin Attenuates High Glucose-Induced BMSC Dysfunction via the Activation of the PI3K/AKT/Nrf2 Signaling Pathway. Drug design, development and therapy 16 (2022)